Literature DB >> 34093944

Integrative analysis of somatic mutations and differential expression profiles in glioblastoma based on aging acceleration.

Huize Wang1,2, Shiyan Li3, Hongxin Liu3, Shiyu Bian4, Wanjiang Huang5, Chengzhong Xing2, Yin Wang2,3.   

Abstract

BACKGROUND: Glioblastoma (GBM) is an aggressive brain tumor and the mechanisms of progression are very complex. Accelerated aging is a driving factor of GBM. However, there has not been thorough research about the mechanisms of GBM progression based on aging acceleration.
METHODS: The aging predictor was modeled based on normal brain samples. Then an aging acceleration background network was constructed to explore GBM mechanisms.
RESULTS: The accelerated aging-related mechanisms provided an innovative way to study GBM, wherein integrative analysis of somatic mutations and differential expression revealed key pathologic characteristics. Moreover, the influence of the immune system, the nervous system and other critical factors on GBM were identified. The survival analysis also disclosed crucial GBM markers.
CONCLUSION: An integrative analysis of multi-omics data based on aging acceleration identified new driving factors for GBM. IJCEP
Copyright © 2021.

Entities:  

Keywords:  Aging; glioblastoma; integrative analysis; network analysis

Year:  2021        PMID: 34093944      PMCID: PMC8167488     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  33 in total

Review 1.  Leukocytosis.

Authors:  D S Chabot-Richards; T I George
Journal:  Int J Lab Hematol       Date:  2014-06       Impact factor: 2.877

Review 2.  Relevance of TP53 for CLL diagnostics.

Authors:  Mark A Catherwood; David Gonzalez; David Donaldson; Ruth Clifford; Ken Mills; Patrick Thornton
Journal:  J Clin Pathol       Date:  2019-02-02       Impact factor: 3.411

Review 3.  Mast cell activation syndromes.

Authors:  Cem Akin
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

Review 4.  Decoding the link between WWOX and p53 in aggressive breast cancer.

Authors:  Suhaib K Abdeen; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2019-05-16       Impact factor: 4.534

Review 5.  Molecular Pathways Underlying Projection Neuron Production and Migration during Cerebral Cortical Development.

Authors:  Chiaki Ohtaka-Maruyama; Haruo Okado
Journal:  Front Neurosci       Date:  2015-12-17       Impact factor: 4.677

6.  CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.

Authors:  Philip N Dannhauser; Stéphane M Camus; Kazuho Sakamoto; L Amanda Sadacca; Jorge A Torres; Marine D Camus; Kit Briant; Stéphane Vassilopoulos; Alice Rothnie; Corinne J Smith; Frances M Brodsky
Journal:  J Biol Chem       Date:  2017-11-02       Impact factor: 5.157

Review 7.  Interaction between Rho GTPases and 14-3-3 Proteins.

Authors:  Daniel Brandwein; Zhixiang Wang
Journal:  Int J Mol Sci       Date:  2017-10-15       Impact factor: 5.923

8.  Identification of an early cell fate regulator by detecting dynamics in transcriptional heterogeneity and co-regulation during astrocyte differentiation.

Authors:  Tatsuya Ando; Ryuji Kato; Hiroyuki Honda
Journal:  NPJ Syst Biol Appl       Date:  2019-05-08

9.  Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia.

Authors:  Salih Demir; Elena Boldrin; Qian Sun; Stephanie Hampp; Eugen Tausch; Cornelia Eckert; Martin Ebinger; Rupert Handgretinger; Geertruy Te Kronnie; Lisa Wiesmüller; Stephan Stilgenbauer; Galina Selivanova; Klaus-Michael Debatin; Lüder Hinrich Meyer
Journal:  Haematologica       Date:  2019-05-09       Impact factor: 9.941

10.  Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin‑resistant breast cancer cells.

Authors:  Chunjie Wen; Lijuan Fu; Jiafeng Huang; Yi Dai; Bin Wang; Ge Xu; Lanxiang Wu; Honghao Zhou
Journal:  Mol Med Rep       Date:  2019-04-22       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.